0120G0 Stock Chart & Stats
₩48400.00
-₩800.00(-1.63%)
―
--
Day’s Range― - ―
52-Week Range₩23,250.00 - ₩150,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)78.86K
Market Cap
₩365.56B
Enterprise Value₩346.97K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,435,870
10 Day Avg. Volume26,223
30 Day Avg. Volume78,859
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
0120G0 FAQ
What was Samyang Biopharm Corporation’s price range in the past 12 months?
Samyang Biopharm Corporation lowest stock price was ₩23250.00 and its highest was ₩150900.00 in the past 12 months.
What is Samyang Biopharm Corporation’s market cap?
Samyang Biopharm Corporation’s market cap is ₩365.56B.
When is Samyang Biopharm Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Samyang Biopharm Corporation’s earnings last quarter?
Currently, no data Available
Is Samyang Biopharm Corporation overvalued?
According to Wall Street analysts Samyang Biopharm Corporation’s price is currently Undervalued.
Does Samyang Biopharm Corporation pay dividends?
Samyang Biopharm Corporation does not currently pay dividends.
What is Samyang Biopharm Corporation’s EPS estimate?
Samyang Biopharm Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Samyang Biopharm Corporation have?
Samyang Biopharm Corporation has 7,435,870 shares outstanding.
What happened to Samyang Biopharm Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Samyang Biopharm Corporation?
Currently, no hedge funds are holding shares in KR:0120G0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Hans Biomed Corp
―
Huons Global Co., Ltd.
―
NeoPharm Co., Ltd.
―
HUONS CO., LTD
―
Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh
―